BackSensus Healthcare Overview

Sensus Healthcare Total Revenue

Latest total revenue for SRTS: $18M, below the Healthcare sector average of $110B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Revenue

$2.29M
68.69% YoY

As of Jun 2026

Annual Revenue (TTM)

$17.51M
53.39% YoY

Trailing 12 months ending Jun 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading

Sensus Healthcare (SRTS) FAQ

Sensus Healthcare (SRTS) currently reports a total revenue of $18M as of June 2026. That compares with $38M in the prior-year period — down 53.4% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Sensus Healthcare's total revenue history and peer comparisons.

Sensus Healthcare's total revenue decreased from $38M to $18M — a 53.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sensus Healthcare's total revenue of $18M is lower than the Healthcare sector average of $110B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Sensus Healthcare reported $18M in total revenue as of June 2026. That compares with $38M in the prior-year period — down 53.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $18M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Sensus Healthcare, and consider following SRTS for alerts when major investors trade the stock.